한미사이언스

008930KOSPI기타 금융업

61.9 / 100

Reference Date: 2026-07-24

Financial Score20.5 / 40

News Sentiment17.4 / 25

Momentum14.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Surged 22.2% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Hanmi Science operates as a business holding company, generating revenue through equity income from subsidiaries, patent and trademark licensing fees, and healthcare and pharmaceutical wholesale businesses. The company focuses on innovation across medical devices, food, beauty care, and IT solutions, and expanded its portfolio through the 2022 acquisition of Hanmi Healthcare.

Number of Employees

489people

Average Salary

72.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

19.96Industry Average 7.940.0Point

2.5x industry avg (risky)

PBR

2.45Industry Average 0.450.0Point

5.4x industry avg (risky)

ROE

13.09Industry Average 5.457.0Point

2.4x industry avg (excellent)

Debt Ratio

4.83Industry Average 16.998.0Point

Half of industry avg (excellent)

Trend 2023~20255.5 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲4.3% (2-year basis)

Operating Profit Growth Rate

2.0 / 3

Avg ▲9.9% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 11.8% (declining, 3yr)

Detailed News Sentiment

44 totalPositive 23Neutral 9Negative 12Average Sentiment Score 69.5

Positive
"상생으로 함께 성장"…한미그룹, 청각장애인 바리스타의 꿈 지원
한미그룹의 사회공헌 활동이 긍정적 이미지 제고에 기여하며 기업의 사회적 책임 강화를 보여주고 있다.
Positive
한미사이언스, 지식재산처장 표창…"경쟁력 인정"
한미사이언스의 IP팀 팀장 한지연 상무가 지식재산 관련 유공자로 선정되어 회사의 기술력과 경쟁력이 인정받았다.
Positive
한미사이언스, 글로벌 'IP 역량' 강화에 속도
한미사이언스의 IP 역량 강화로 신약 개발 초기 단계부터 체계적인 전략 운영이 인정받아 긍정적인 시장 반응 예상.

Detailed Momentum

52-week position3.0Point

52w lower range (31%)

Current 34,350Won52-week high 51,90052-week low 26,100

1-month return6.0Point

1m +22.24% (strong rise)

Volume trend5.0Point

Volume increasing

Detailed Disclosure

14 totalPositive 0Neutral 14Negative 0

Neutral주요사항보고서(자기주식처분결정)(자회사의 주요경영사항)2026-07-20
Neutral결산실적공시예고(안내공시)2026-07-14
Neutral주식등의대량보유상황보고서(일반)2026-07-10
Neutral주식등의대량보유상황보고서(일반)2026-07-10
Neutral주식등의대량보유상황보고서(일반)2026-07-07